miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s disease

Parkinson’s Disease is the second most common neurodegenerative disorder, affecting 1–2% of the elderly population. Its diagnosis is still based on the identification of motor symptoms when a considerable number of dopaminergic neurons are already lost. The development of translatable biomarkers for...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: dos Santos, Marcia Cristina T., Barreto-Sanz, Miguel Arturo, Correia, Bruna Renata S., Bell, Rosie, Widnall, Catherine, Perez, Luis Tosar, Berteau, Caroline, Schulte, Claudia, Scheller, Dieter, Berg, Daniela, Maetzler, Walter, Galante, Pedro A.F., Nogueira da Costa, Andre
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2018
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5915128/
https://ncbi.nlm.nih.gov/pubmed/29707120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24736
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi